These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22394042)

  • 1. Matrix metalloproteinases and their inhibitors in correlation to proliferative and classical tumour markers during surgical therapy of colorectal liver metastases.
    Liska V; Sutnar A; Holubec L; Vrzalova J; Treska V; Skalicky T; Pesta M; Kormunda S; Finek J; Rousarova M; Topolcan O
    Bratisl Lek Listy; 2012; 113(2):108-13. PubMed ID: 22394042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New clinical scoring system for prognosis of early recurrence of colorectal liver metastases after surgical treatment.
    Alan S; Vaclav L; Martin P; Vladislav T; Ondrej T; Tomas S; Stanislav K; Lubos H
    Hepatogastroenterology; 2011; 58(109):1286-90. PubMed ID: 21937396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of serum levels of tumour markers and prognosis of recurrence and survival after liver surgery for colorectal liver metastases.
    Liska V; Holubec L; Treska V; Skalicky T; Sutnar A; Kormunda S; Pesta M; Finek J; Rousarova M; Topolcan O
    Anticancer Res; 2007; 27(4C):2861-4. PubMed ID: 17695461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement.
    Nyström H; Tavelin B; Björklund M; Naredi P; Sund M
    Tumour Biol; 2015 Dec; 36(12):9839-47. PubMed ID: 26162539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How to predict the relapse after surgery or radiofrequency of liver metastases of colorectal cancer? Interest of the serum kinetic variation of a matrix metalloproteinase cluster].
    Frenoux C; Rebischung C; Quesada JL; Mendosa C; Letoublon C; Trocmé C
    Bull Cancer; 2018 Oct; 105(10):884-895. PubMed ID: 30243479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.
    Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Hirakawa K; Ohira M
    Anticancer Res; 2019 Sep; 39(9):5039-5045. PubMed ID: 31519612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA tissue samples from colorectal liver metastases.
    Sutnar A; Pesta M; Liska V; Treska V; Skalicky T; Kormunda S; Topolcan O; Cerny R; Holubec L
    Tumour Biol; 2007; 28(5):247-52. PubMed ID: 17992052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative tumor markers as prognostic factors of colorectal liver metastases.
    Treska V; Topolcan O; Stanislav K; Liska V; Holubec L
    Hepatogastroenterology; 2009; 56(90):317-20. PubMed ID: 19579590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases.
    Gentner B; Wein A; Croner RS; Zeittraeger I; Wirtz RM; Roedel F; Dimmler A; Dorlaque L; Hohenberger W; Hahn EG; Brueckl WM
    Anticancer Res; 2009 Jan; 29(1):67-74. PubMed ID: 19331134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy.
    Hanke B; Wein A; Martus P; Riedel C; Voelker M; Hahn EG; Schuppan D
    Br J Cancer; 2003 Apr; 88(8):1248-50. PubMed ID: 12698191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population-based analysis on the rate and surgical management of colorectal liver metastases in Southern Germany.
    Hackl C; Gerken M; Loss M; Klinkhammer-Schalke M; Piso P; Schlitt HJ
    Int J Colorectal Dis; 2011 Nov; 26(11):1475-81. PubMed ID: 21748289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis.
    Omichi K; Shindoh J; Cloyd JM; Mizuno T; Chun YS; Conrad C; Aloia TA; Tzeng CD; Vauthey JN
    Eur J Surg Oncol; 2018 Jan; 44(1):122-129. PubMed ID: 29208318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
    Bakalakos EA; Burak WE; Young DC; Martin EW
    Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.
    Allard MA; Adam R; Ruiz A; Vibert E; Paule B; Levi F; Sebagh M; Guettier C; Azoulay D; Castaing D
    Eur J Surg Oncol; 2013 Sep; 39(9):981-7. PubMed ID: 23845705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.
    Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR
    Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
    Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
    Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors.
    Murashige M; Miyahara M; Shiraishi N; Saito T; Kohno K; Kobayashi M
    Jpn J Clin Oncol; 1996 Oct; 26(5):303-9. PubMed ID: 8895669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of outcomes and treatment safety of patients with metastatic colorectal cancer to the liver with estimation of prognostic factors.
    Zeman M; Maciejewski A; Półtorak S; Kryj M
    Pol Przegl Chir; 2013 Jun; 85(6):333-9. PubMed ID: 23828415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Colorectal liver metastases surgery - the present and the perspectives].
    Třeška V; Skalický T; Ferda J; Fínek J; Liška V
    Rozhl Chir; 2014 Dec; 93(12):568-71. PubMed ID: 25472561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.
    Zeng ZS; Guillem JG
    Br J Cancer; 1995 Sep; 72(3):575-82. PubMed ID: 7669564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.